Sodium Morrhuate

Known as: MORRHUATE SODIUM, Morrhuate, Sodium, Sodium, Morrhuate 
The sodium salts of the fatty acids in cod liver oil; an irritant and sclerosing agent used to treat varicose veins and arthritic joints.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
OBJECTIVES This study determined whether injection with hypertonic dextrose and morrhuate sodium (prolotherapy) using a pragmatic… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
Is this relevant?
2013
2013
OBJECTIVE Chronic lateral epicondylosis is common, debilitating, and often refractory. Prolotherapy (PrT) is an injection therapy… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2007
2007
BACKGROUND Obesity affects more than 30% of the U.S. population and is associated with the development of life-threatening… (More)
Is this relevant?
2004
2004
Two hundred and sixty patients with oral and facial venous malformations received intralesional injections of either… (More)
Is this relevant?
1994
1994
Thirty-one patients with knee effusions associated with rheumatoid arthritis (RA) have been treated with two intraarticular (i.a… (More)
Is this relevant?
1991
1991
Forty-five cirrhotic patients with oesophageal varices were randomized to receive endoscopic injection sclerotherapy with either… (More)
Is this relevant?
1986
1986
We determined quantitatively the amount of sodium morrhuate that reaches the pulmonary vascular bed during endoscopic variceal… (More)
Is this relevant?
1985
1985
The purpose of this study was to determine some of the morphological and biochemical effects of sodium morrhuate injections into… (More)
Is this relevant?
1985
1985
Stimulated by a patient with dyspnea, thrombocytopenia, and leukopenia after sodium morrhuate sclerotherapy, we studied the… (More)
Is this relevant?
1983
1983
Two of 30 patients with esophageal varices had respiratory distress develop within 8-24 h of esophageal sclerotherapy. Evidence… (More)
Is this relevant?